News Daily News MISTRAL: No Lasting Benefit from Early Abciximab in STEMI Patients Caitlin E. Cox February 09, 2012
News Daily News High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated Jason Kahn October 24, 2011
News Conference News GRAVITAS Analysis: Lower Cutpoint May Enhance Functional Platelet Testing August 30, 2011
News Conference News ASCOT: Unexplained Long-Term Mortality Benefit Found with Atorvastatin August 29, 2011
News Conference News RECLOSE 2-ACS: Poor Responders Show Poor Outcomes Despite Higher Clopidogrel Dose Caitlin E. Cox May 18, 2011
News Daily News PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact May 02, 2011
News Daily News GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders L.A. McKeown March 15, 2011
News Daily News High-Dose Maintenance Clopidogrel Lowers Platelet Reactivity, Other Risk Factors February 06, 2011
CME A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI